Bradley Mark T. - 29 Mar 2022 Form 4 Insider Report for Endo International plc

Reporting relationship: EVP, Chief Financial Officer
Issuer ticker: N/A
Reported as of: 29 Mar 2022
Net transaction value: -$14,115
SEC form: 4
Accepted by SEC: 31 Mar 2022, 16:03:46 UTC
Prior SEC filing: 08 Mar 2022
Next SEC filing: 04 Aug 2025
Source filing: View source filing
Reporting owner signature: /s/ Matthew J. Maletta, by power of attorney

Key filing fact

Bradley Mark T. filed Form 4 for Endo International plc on 31 Mar 2022.

Key facts

This page summarizes Bradley Mark T.'s Form 4 filing for Endo International plc.
4 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 31 Mar 2022, 16:03.

Change

Previous filing in this sequence was filed on 08 Mar 2022.
Current net transaction value: -$14,115.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ENDPQ transaction

Ordinary Shares

Tax liability

Transaction value: $6,411
Shares: -2,544
Change %: -2.6%
Price: $2.52^*
Shares after: 93,799
Date: 29 Mar 2022
Ownership: Direct
Footnotes: F1, F2, F3

ENDPQ transaction

Stock Incentive Plan Performance Share Units

Options Exercise

Transaction value: $0
Shares: -26,805
Change %: -10%
Price: $0.000000
Shares after: 241,060
Date: 30 Mar 2022
Ownership: Direct
Footnotes: F4, F5, F6

ENDPQ transaction

Ordinary Shares

Options Exercise

Transaction value: $0
Shares: +10,735
Change %: +11%
Price: $0.000000
Shares after: 104,534
Date: 30 Mar 2022
Ownership: Direct
Footnotes: F4, F7

ENDPQ transaction

Ordinary Shares

Tax liability

Transaction value: $7,704
Shares: -3,057
Change %: -2.9%
Price: $2.52^*
Shares after: 101,477
Date: 30 Mar 2022
Ownership: Direct
Footnotes: F3, F4, F8

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 8 footnotes

Footnote F1

Thirty-three and one-third percent (33 1/3%) of Mr. Bradley's March 29, 2019 grant of restricted stock units (RSUs) vested on March 29, 2022.

Footnote F2

These shares represent stock withheld by Endo International plc to satisfy Mr. Bradley's tax withholding obligations on shares acquired upon vesting of RSUs.

Footnote F3

Represents the vesting price which is the average of the high and low share price on March 29, 2022.

Footnote F4

On March 30, 2022, based on performance against target levels with respect to Mr. Bradley's March 29, 2019 grant of performance share units, these awards were released and the performance share units were converted into 10,735 ordinary shares. Of this amount, 3,057 ordinary shares were withheld by Endo International plc to satisfy Mr. Bradley's tax withholding obligations on shares acquired upon vesting, with the remainder transferred to Mr. Bradley.

Footnote F5

Represents the target number of shares issuable upon Endo International plc's achievement of both: (a) shareholder return performance metrics over a cumulative three-year period and (b) free cash flow performance metrics over a cumulative three-year period, each as determined by Endo International plc's Board of Directors at the end of such periods.

Footnote F6

These securities were granted to Mr. Bradley in consideration of his services as a senior executive of Endo International plc.

Footnote F7

This represents the automatic conversion of performance share units granted to Mr. Bradley on March 29, 2019 to ordinary shares of Endo International plc pursuant to the terms of the underlying award agreement.

Footnote F8

These shares represent stock withheld by Endo International plc to satisfy Mr. Bradley's tax withholding obligations on shares acquired upon vesting of performance share units.